Rafferty Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
|
|||||
|
2025
Q1 | $318K | Sell |
|
|||||
|
2024
Q4 | $307K | Sell |
|
|||||
|
2024
Q3 | $421K | Sell |
|
|||||
|
2024
Q2 | $441K | Sell |
|
|||||
|
2024
Q1 | $548K | Buy |
|
|||||
|
2023
Q4 | $465K | Buy |
|
|||||
|
2023
Q3 | $319K | Buy |
|
|||||
|
2023
Q2 | $313K | Sell |
|
|||||
|
2023
Q1 | $278K | Buy |
|
|||||
|
2022
Q4 | $305K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $373K | Buy |
|
|||||
|
2022
Q1 | $227K | Sell |
|
|||||
|
2021
Q4 | $617K | Sell |
|
|||||
|
2021
Q3 | $574K | Buy |
|
|||||
|
2021
Q2 | $242K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $325K | Sell |
|
|||||
|
2020
Q3 | $290K | Sell |
|
|||||
|
2020
Q2 | $340K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $470K | Sell |
|
|||||
|
2019
Q3 | $260K | Buy |
|